secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0001104659-23-087347
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical Q2 EPS $0.61 (+44% YoY), revenue up 5.7%; declares $0.125 dividend
--------------------------------------------------------------------------------

- Q2 revenue $1,674.5M (+5.7% YoY); net income $91.9M (+38.6% YoY); Adjusted EBITDA $219.5M (+21.3% YoY).
- Critical illness recovery hospital segment Adjusted EBITDA surged 227% to $65.5M; margin 11.4% vs 3.7%.
- Board declared $0.125/share cash dividend, payable Sep 1, 2023 to holders of record Aug 15.
- FY2023 outlook: revenue $6.55-6.7B, Adjusted EBITDA $795-825M, EPS $1.77-1.94, adjusted EPS $1.86-2.03.
- No shares repurchased in H1 2023; $1.0B buyback program expires Dec 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465923087347/0001104659-23-087347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465923087347/tm2322751d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-087347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer